Monitoring and treatment results of 88 HBsAg-positive pregnant women

Basit Öğe Kaydı
dc.contributor.authorKolgelier, S.
dc.contributor.authorSumer, S.
dc.contributor.authorDemir, N. A.
dc.contributor.authorAsci, Z.
dc.contributor.authorDemir, L. S.
dc.contributor.authorOzcimen, S.
dc.contributor.authorUral, O.
dc.date.accessioned2024-02-23T14:29:15Z
dc.date.available2024-02-23T14:29:15Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstractApproximately 5% of all women in the world are HBsAg-positive. Chronic hepatitis B is a problem in women of reproductive age. This paper assessed 88 HBsAg-positive pregnant women, of whom 11 began treatment during pregnancy and five became pregnant while receiving treatment. The files of HBsAg-positive pregnant women were reviewed between January 2010 and December 2013 retrospectively. From these 88 pregnant women, 72 did not receive any treatment during their pregnancy, 11 began treatment during their pregnancy, and five became pregnant while receiving treatment. Nine of these 11 pregnant women were given tenofovir disoproxil fumarate and two of them lamivudine. Ten babies of the 11 mothers that began treatment during their pregnancy were healthy, but one was lost due to preterm birth. Of the five patients who became pregnant while receiving treatment, the treatments of four women were discontinued and they were monitored during their pregnancies because mild -moderate (less than stage 3) fibrosis was found in their liver biopsy results. It is important to screen all pregnant women for hepatitis B and to assess those found HBsAg-positive. It is possible to protect both the mother and baby using appropriate approaches.en_US
dc.identifier.doi10.12891/ceog3128.2016
dc.identifier.endpage870en_US
dc.identifier.issn0390-6663
dc.identifier.issue6en_US
dc.identifier.pmid29944240en_US
dc.identifier.scopus2-s2.0-85008674752en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage866en_US
dc.identifier.urihttps://doi.org/10.12891/ceog3128.2016
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14631
dc.identifier.volume43en_US
dc.identifier.wosWOS:000388785400018en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherI R O G Canada, Incen_US
dc.relation.ispartofClinical And Experimental Obstetrics & Gynecologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic Hepatitis Ben_US
dc.subjectPregnancyen_US
dc.subjectTreatmenten_US
dc.titleMonitoring and treatment results of 88 HBsAg-positive pregnant womenen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu